Department of Pediatric Oncology, Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan.
J Coll Physicians Surg Pak. 2021 Nov;31(11):1372-1374. doi: 10.29271/jcpsp.2021.11.1372.
The aim of this study was to determine how the COVID-19 pandemic impacted on the effective management; and the outcome of pediatric oncology patients in Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore. Data was retrospectively reviewed from 15 March to 15 June 2020 after the approval of Institutional Review Board Committee. A total of 258 patients on active oncology treatment between the study period were included. The total number of patients whose treatment was affected were 118 (45.7%), while 140 (54.3%) patients received treatment in time. There was total 34 (13.2%) patients relapsed, 23 (67.6%) patients in which treatment delayed, and 11 (32.4%) patients in which their treatment not delayed; while, n=218 (84.5%) were in remission, and 6 (2.3%) patients absconded. COVID-19 pandemic caused a sudden impediment in the treatment of pediatric oncology patients, and is likely to affect the long-term survival outcome of pediatric oncology patients. Key Words: Chemotherapy, Radiotherapy, Surgery, Long term outcome.
本研究旨在确定 COVID-19 大流行对巴基斯坦拉合尔沙迦汗姆纪念癌症医院和研究中心儿科肿瘤患者的有效管理和治疗结果的影响。在获得机构审查委员会的批准后,于 2020 年 3 月 15 日至 6 月 15 日对数据进行了回顾性审查。在研究期间,共有 258 名接受肿瘤学治疗的患者入组。共有 118 名(45.7%)患者的治疗受到影响,140 名(54.3%)患者及时接受了治疗。共有 34 名(13.2%)患者复发,23 名(67.6%)患者治疗延迟,11 名(32.4%)患者治疗未延迟;218 名(84.5%)患者缓解,6 名(2.3%)患者潜逃。COVID-19 大流行突然阻碍了儿科肿瘤患者的治疗,可能会影响儿科肿瘤患者的长期生存结果。关键词:化疗、放疗、手术、长期结果。